{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T10:44:28Z","timestamp":1781779468044,"version":"3.54.5"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100017501","name":"Science Health Joint Medical Scientific Research Project of Chongqing","doi-asserted-by":"publisher","award":["2020MSXM089"],"award-info":[{"award-number":["2020MSXM089"]}],"id":[{"id":"10.13039\/100017501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jmoldx.2023.02.003","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T05:59:31Z","timestamp":1684303171000},"page":"342-351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Comparison of the Diagnostic Performance of MeltPro and Next-Generation Sequencing in Determining Fluoroquinolone Resistance in Multidrug-Resistant Tuberculosis Isolates"],"prefix":"10.1016","volume":"25","author":[{"given":"Yan","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhua","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6803-9807","authenticated-orcid":false,"given":"Yu","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2023.02.003_bib1","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0140-6736(10)60410-2","article-title":"Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis","volume":"375","author":"Gandhi","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1105\/tpc.105.040303","article-title":"Transcriptome profiling, molecular biological, and physiological studies reveal a major role for ethylene in cotton fiber cell elongation","volume":"18","author":"Shi","year":"2006","journal-title":"Plant Cell"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib3","series-title":"Global tuberculosis report 2021","year":"2021"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib4","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3201\/eid2106.141873","article-title":"Acquired drug resistance in mycobacterium tuberculosis and poor outcomes among patients with multidrug-resistant tuberculosis","volume":"21","author":"Kempker","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib5","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.2174\/138161211797470200","article-title":"Fluoroquinolones, the cornerstone of treatment of drug-resistant tuberculosis: a pharmacokinetic and pharmacodynamic approach","volume":"17","author":"Pranger","year":"2011","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib6","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1089\/mdr.2019.0339","article-title":"Genotyping and molecular characterization of fluoroquinolone's resistance among multidrug-resistant mycobacterium tuberculosis in Southwest of China","volume":"27","author":"Hu","year":"2021","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib7","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1128\/AAC.47.10.3117-3122.2003","article-title":"Fluoroquinolone-containing third-line regimen against mycobacterium tuberculosis in\u00a0vivo","volume":"47","author":"Veziris","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s40265-018-1043-y","article-title":"The role of fluoroquinolones in the treatment of tuberculosis in 2019","volume":"79","author":"Pranger","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib9","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1086\/598196","article-title":"Empirical treatment of community-acquired pneumonia and the development of fluoroquinolone-resistant tuberculosis","volume":"48","author":"Long","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib10","doi-asserted-by":"crossref","first-page":"e02170","DOI":"10.1128\/AAC.02170-16","article-title":"Genotyping and prevalence of pyrazinamide- and moxifloxacin-resistant tuberculosis in China, 2000 to 2010","volume":"61","author":"Pang","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib11","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cmi.2018.03.041","article-title":"Evaluation of whole genome sequencing and software tools for drug susceptibility testing of mycobacterium tuberculosis","volume":"25","author":"van Beek","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib12","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/resp.13393","article-title":"Drug resistance mechanisms and drug susceptibility testing for tuberculosis","volume":"23","author":"Miotto","year":"2018","journal-title":"Respirology"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib13","doi-asserted-by":"crossref","first-page":"e01582","DOI":"10.1128\/JCM.01582-19","article-title":"Advances in molecular diagnosis of tuberculosis","volume":"58","author":"MacLean","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3201\/eid0702.010239","article-title":"Emerging mechanisms of fluoroquinolone resistance","volume":"7","author":"Hooper","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib15","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.1128\/AAC.00287-09","article-title":"Fluoroquinolone resistance in mycobacterium tuberculosis and mutations in gyrA and gyrB","volume":"53","author":"Von Groll","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib16","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S1473-3099(21)00452-7","article-title":"Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB\/XDR assay: a cross-sectional multicentre diagnostic accuracy study","volume":"22","author":"Penn-Nicholson","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jmoldx.2012.08.004","article-title":"Underestimation of the resistance of mycobacterium tuberculosis to second-line drugs by the new GenoType MTBDRsl test","volume":"15","author":"Jin","year":"2013","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib18","doi-asserted-by":"crossref","first-page":"25330","DOI":"10.1038\/srep25330","article-title":"Rapid diagnosis of MDR and XDR tuberculosis with the MeltPro TB assay in China","volume":"6","author":"Pang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib19","doi-asserted-by":"crossref","first-page":"e00717","DOI":"10.1128\/JCM.00717-19","article-title":"How well do routine molecular diagnostics detect rifampin heteroresistance in mycobacterium tuberculosis?","volume":"57","author":"Ng","year":"2019","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib20","doi-asserted-by":"crossref","first-page":"e32976","DOI":"10.1371\/journal.pone.0032976","article-title":"Spoligotyping and drug resistance analysis of mycobacterium tuberculosis strains from national survey in China","volume":"7","author":"Pang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib21","series-title":"Global tuberculosis report 2019","year":"2019"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib22","doi-asserted-by":"crossref","first-page":"e0216018","DOI":"10.1371\/journal.pone.0216018","article-title":"Epidemiology of drug-resistant tuberculosis in Chongqing, China: a retrospective observational study from 2010 to 2017","volume":"14","author":"Wu","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib23","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1186\/s12864-019-5986-5","article-title":"Transcriptome analysis reveals differences in the mechanisms of fiber initiation and elongation between long- and short-fiber cotton (Gossypium hirsutum L.) lines","volume":"20","author":"Qin","year":"2019","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib24","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1128\/AAC.01228-13","article-title":"Prevalence and molecular characterization of fluoroquinolone-resistant mycobacterium tuberculosis isolates in China","volume":"58","author":"Zhang","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib25","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1128\/JCM.43.6.2996-2997.2005","article-title":"Extraction of Mycobacterium tuberculosis DNA: a question of containment","volume":"43","author":"Somerville","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib26","doi-asserted-by":"crossref","first-page":"4563826","DOI":"10.1155\/2017\/4563826","article-title":"Prevalence and molecular characterization of second-line drugs resistance among multidrug-resistant mycobacterium tuberculosis isolates in Southwest of China","volume":"2017","author":"Hu","year":"2017","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib27","doi-asserted-by":"crossref","first-page":"754352","DOI":"10.3389\/fmicb.2021.754352","article-title":"Distinguishing relapse from reinfection with whole-genome sequencing in recurrent pulmonary tuberculosis: a retrospective cohort study in Beijing, China","volume":"12","author":"Du","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13073-019-0650-x","article-title":"Integrating informatics tools and portable sequencing technology for rapid detection of resistance to anti-tuberculous drugs","volume":"11","author":"Phelan","year":"2019","journal-title":"Genome Med"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib29","doi-asserted-by":"crossref","first-page":"106401","DOI":"10.1016\/j.ijantimicag.2021.106401","article-title":"Genomic-based surveillance reveals high ongoing transmission of multi-drug-resistant mycobacterium tuberculosis in Southern Brazil","volume":"58","author":"Salvato","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib30","doi-asserted-by":"crossref","first-page":"102286","DOI":"10.1016\/j.tube.2022.102286","article-title":"Genetic mutations underlying isoniazid-resistant mycobacterium tuberculosis in Khyber Pakhtunkhwa, Pakistan","volume":"138","author":"Khan","year":"2022","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib32","doi-asserted-by":"crossref","first-page":"102120","DOI":"10.1016\/j.tube.2021.102120","article-title":"Deep whole-genome sequencing reveals no evidence for heteroresistance influencing treatment outcomes among drug-susceptible tuberculosis patients","volume":"130","author":"Chen","year":"2021","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib31","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/infdis\/jis601","article-title":"Dynamic population changes in mycobacterium tuberculosis during acquisition and fixation of drug resistance in patients","volume":"206","author":"Sun","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib33","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/jac\/dks033","article-title":"gyrA mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of mycobacterium tuberculosis","volume":"67","author":"Sirgel","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ijid.2020.01.021","article-title":"Increased prevalence of levofloxacin-resistant mycobacterium tuberculosis in China is associated with specific mutations within the gyrA gene","volume":"92","author":"Huo","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib35","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/jac\/dkr173","article-title":"Molecular basis and mechanisms of drug resistance in mycobacterium tuberculosis: classical and new drugs","volume":"66","author":"Almeida Da Silva","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib36","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1128\/AAC.02066-13","article-title":"High proportion of heteroresistance in gyrA and gyrB in fluoroquinolone-resistant mycobacterium tuberculosis clinical isolates","volume":"58","author":"Eilertson","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib37","doi-asserted-by":"crossref","first-page":"11760","DOI":"10.1038\/s41598-019-48289-9","article-title":"Fluoroquinolone heteroresistance in mycobacterium tuberculosis: detection by genotypic and phenotypic assays in experimentally mixed populations","volume":"9","author":"Rigouts","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib38","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1038\/emi.2014.21","article-title":"Association of gyrA\/B mutations and resistance levels to fluoroquinolones in clinical isolates of mycobacterium tuberculosis","volume":"3","author":"Li","year":"2014","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib39","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.jmoldx.2020.06.010","article-title":"Specific gyrA gene mutations correlate with high prevalence of discordant levofloxacin resistance in mycobacterium tuberculosis isolates from Beijing, China","volume":"22","author":"Huo","year":"2020","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib40","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/jac\/dkr566","article-title":"A systematic review of gyrase mutations associated with fluoroquinolone-resistant mycobacterium tuberculosis and a proposed gyrase numbering system","volume":"67","author":"Maruri","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib41","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.3389\/fmicb.2017.01768","article-title":"Rifabutin resistance associated with double mutations in rpoB gene in mycobacterium tuberculosis isolates","volume":"8","author":"Jing","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib42","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fcimb.2018.00114","article-title":"Molecular targets related drug resistance mechanisms in MDR-, XDR-, and TDR-mycobacterium tuberculosis strains","volume":"8","author":"Hameed","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib43","doi-asserted-by":"crossref","first-page":"102091","DOI":"10.1016\/j.tube.2021.102091","article-title":"Drug resistance, fitness and compensatory mutations in Mycobacterium tuberculosis","volume":"129","author":"Alame Emane","year":"2021","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.jmoldx.2023.02.003_bib44","doi-asserted-by":"crossref","first-page":"e0072021","DOI":"10.1128\/AAC.00720-21","article-title":"Detection of pyrazinamide heteroresistance in mycobacterium tuberculosis","volume":"65","author":"Werngren","year":"2021","journal-title":"Antimicrob Agents Chemother"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157823000466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157823000466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:17:35Z","timestamp":1761502655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157823000466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1525157823000466"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2023.02.003","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the Diagnostic Performance of MeltPro and Next-Generation Sequencing in Determining Fluoroquinolone Resistance in Multidrug-Resistant Tuberculosis Isolates","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2023.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}